459 related articles for article (PubMed ID: 37371134)
1. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.
Russo E; Corrao S; Di Gaudio F; Alberti G; Caprnda M; Kubatka P; Kruzliak P; Miceli V; Conaldi PG; Borlongan CV; La Rocca G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371134
[TBL] [Abstract][Full Text] [Related]
2. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord: an allogenic tissue for potential treatment of COVID-19.
Rodriguez HC; Gupta M; Cavazos-Escobar E; El-Amin SF; Gupta A
Hum Cell; 2021 Jan; 34(1):1-13. PubMed ID: 33033884
[TBL] [Abstract][Full Text] [Related]
4. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
Khanh VC; Fukushige M; Chang YH; Hoang NN; Yamashita T; Obata-Yasuoka M; Hamada H; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2021 Aug; 30(15):758-772. PubMed ID: 34074129
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
Ringdén O; Moll G; Gustafsson B; Sadeghi B
Front Immunol; 2022; 13():839844. PubMed ID: 35371003
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19.
Taufiq H; Shaik Fakiruddin K; Muzaffar U; Lim MN; Rusli S; Kamaluddin NR; Esa E; Abdullah S
Ther Adv Respir Dis; 2023; 17():17534666231158276. PubMed ID: 37128999
[TBL] [Abstract][Full Text] [Related]
8. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
[TBL] [Abstract][Full Text] [Related]
9. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Ganjali R; Tafreshian AR; Tavakol-Afshari J
Stem Cell Res Ther; 2022 Jun; 13(1):283. PubMed ID: 35765103
[TBL] [Abstract][Full Text] [Related]
11. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.
Monsel A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Nguekap Tchoumba O; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Malard-Castagnet S; Burrel S; Rosenzwajg M; Tchitchek N; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Ropers J; Menasché P; Larghero J;
Crit Care; 2022 Feb; 26(1):48. PubMed ID: 35189925
[TBL] [Abstract][Full Text] [Related]
12. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
[TBL] [Abstract][Full Text] [Related]
13. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial.
Dilogo IH; Aditianingsih D; Sugiarto A; Burhan E; Damayanti T; Sitompul PA; Mariana N; Antarianto RD; Liem IK; Kispa T; Mujadid F; Novialdi N; Luviah E; Kurniawati T; Lubis AMT; Rahmatika D
Stem Cells Transl Med; 2021 Sep; 10(9):1279-1287. PubMed ID: 34102020
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Administration of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) for Acute Respiratory Distress Syndrome Due to COVID-19 Infection.
Perez JA; Parcero Valdes JJ; Corral Moreno R; Gomez Cuevas LI; Lopez JJ; Ichim T; McGreevy K; Lin F; Kesari S; Datta S
Cureus; 2023 Aug; 15(8):e44110. PubMed ID: 37638263
[TBL] [Abstract][Full Text] [Related]
15. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.
Sitbon A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Lebbah S; Ropers J; Salem JE; Straus C; Menasché P; Larghero J; Monsel A;
Stem Cell Res Ther; 2024 Apr; 15(1):109. PubMed ID: 38637891
[TBL] [Abstract][Full Text] [Related]
16. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
17. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M; Shahrbaf MA; Nouri M; Shekari F; Hosseini SE; Hashemian SR; Aliannejad R; Jamaati H; Khavandgar N; Alemi H; Madani H; Nazari A; Amini A; Hassani SN; Abbasi F; Jarooghi N; Fallah N; Taghiyar L; Ganjibakhsh M; Hajizadeh-Saffar E; Vosough M; Baharvand H
Stem Cell Res Ther; 2023 Jun; 14(1):169. PubMed ID: 37365605
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal Cells from Different Parts of Umbilical Cord: Approach to Comparison & Characteristics.
Semenova E; Grudniak MP; Machaj EK; Bocian K; Chroscinska-Krawczyk M; Trochonowicz M; Stepaniec IM; Murzyn M; Zagorska KE; Boruczkowski D; Kolanowski TJ; Oldak T; Rozwadowska N
Stem Cell Rev Rep; 2021 Oct; 17(5):1780-1795. PubMed ID: 33860454
[TBL] [Abstract][Full Text] [Related]
19. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D
Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]